Literature DB >> 17273004

Mirizzi syndrome complicating an anomalous biliary tract: a novel cause of a hugely elevated CA19-9.

Andrew G N Robertson1, Brian R Davidson.   

Abstract

A 71-year-old man presented with painful obstructive jaundice, weight loss and an elevated CA19-9 (>16,000 U/ml) (normal levels <39 U/ml). Imaging showed a hilar mass. After biliary stenting, the CA19-9 returned to normal. At surgery, biliary obstruction owing to a gallstone (Type II Mirizzi) was found to be complicating a congenital biliary tract anomaly. The obstructing stone was removed and the anomalous biliary tract reconstructed with a Roux-en-y loop, and the patient made an uneventful recovery and remained normal over a 2-year follow-up. A Type II Mirizzi with a biliary tract anomaly is an undocumented cause of an elevated CA19-9. The possibility of benign disease must be considered even with very high levels of the cancer marker CA19-9 or the opportunity for curative surgery may be missed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17273004     DOI: 10.1097/MEG.0b013e3280122879

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  10 in total

1.  Mirizzi's syndrome: a diagnostic dilemma.

Authors:  I N Masih; R J Moorehead; G R Caddy
Journal:  Ir J Med Sci       Date:  2009-04-15       Impact factor: 1.568

2.  Clinical experience with primary hepatic epithelioid hemangioendothelioma: retrospective study of 33 patients.

Authors:  Long-Rong Wang; Jia-Min Zhou; Yi-Ming Zhao; Hong-Wei He; Zong-Tao Chai; Miao Wang; Yuan Ji; Yi Chen; Chen Liu; Hui-Chuan Sun; Wei-Zhong Wu; Qing-Hai Ye; Jian Zhou; Jia Fan; Zhao-You Tang; Lu Wang
Journal:  World J Surg       Date:  2012-11       Impact factor: 3.352

3.  Markers of bile duct tumors.

Authors:  Giulia Malaguarnera; Maria Giordano; Isabella Paladina; Alessandra Rando; Mario Uccello; Francesco Basile; Antonio Biondi; Santo Carnazzo; Innocenza Alessandria; Clorinda Mazzarino
Journal:  World J Gastrointest Oncol       Date:  2011-04-15

4.  Mirizzi syndrome: history, current knowledge and proposal of a simplified classification.

Authors:  Marcelo A Beltrán
Journal:  World J Gastroenterol       Date:  2012-09-14       Impact factor: 5.742

5.  Elevation of carbohydrate antigen 19.9 in benign hepatobiliary conditions and its correlation with serum bilirubin concentration.

Authors:  S L Ong; A Sachdeva; G Garcea; G Gravante; M S Metcalfe; D M Lloyd; D P Berry; A R Dennison
Journal:  Dig Dis Sci       Date:  2008-05-09       Impact factor: 3.199

6.  [CA19-9 in intrahepatic cholangiocarcinoma : A diagnostic and prognostic armamentarium?]

Authors:  B Juntermanns; G M Kaiser; S Itani Gutierrez; M Heuer; M Buechter; A Kahraman; H Reis; S Kasper; A Paul; C D Fingas
Journal:  Chirurg       Date:  2018-06       Impact factor: 0.955

7.  Elevation of CA 19-9 in Mirizzi Syndrome in the Absence of Malignancy: A Case Report.

Authors:  Leena H Moshref; Rasha Abdulaziz Mandili; Murouj Almaghrabi; Rahaf Abdulrashid Abdulwahab; Rawan A Alosaimy; Jameel Miro
Journal:  Am J Case Rep       Date:  2021-07-01

8.  Tumor markers as a diagnostic key for hilar cholangiocarcinoma.

Authors:  B Juntermanns; S Radunz; M Heuer; S Hertel; H Reis; J P Neuhaus; S Vernadakis; T Trarbach; A Paul; Gernot M Kaiser
Journal:  Eur J Med Res       Date:  2010-08-20       Impact factor: 2.175

9.  Unusual Case of Mirizzi Syndrome Presenting as Painless Jaundice.

Authors:  Justin Bauzon; Sarah Haller; Jose R Aponte-Pieras; Daisy Lankarani; Ariyon Schreiber; Nazanin Houshmand; Shahid Wahid
Journal:  Am J Case Rep       Date:  2022-08-14

10.  Differential Diagnosis of Immunoglobulin G4-associated Cholangitis From Cholangiocarcinoma.

Authors:  Shunda Du; Gang Liu; Xinqi Cheng; Yue Li; Qian Wang; Ji Li; Xin Lu; Yongchang Zheng; Haifeng Xu; Tianyi Chi; Haitao Zhao; Yiyao Xu; Xinting Sang; Shouxian Zhong; Yilei Mao
Journal:  J Clin Gastroenterol       Date:  2016-07       Impact factor: 3.062

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.